Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy
- 1 September 2015
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 271, 36-45
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Central Nervous System Pathology Progresses Independently of KC and CXCR2 in Globoid-Cell LeukodystrophyPLOS ONE, 2013
- Substrate Compositional Variation with Tissue/Region and Gba1 Mutations in Mouse Models–Implications for Gaucher DiseasePLOS ONE, 2013
- Bone marrow transplantation increases efficacy of central nervous system-directed enzyme replacement therapy in the murine model of globoid cell leukodystrophyMolecular Genetics and Metabolism, 2012
- Bone Marrow Transplantation Augments the Effect of Brain- and Spinal Cord-Directed Adeno-Associated Virus 2/5 Gene Therapy by Altering Inflammation in the Murine Model of Globoid-Cell LeukodystrophyJournal of Neuroscience, 2011
- Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?Human Molecular Genetics, 2011
- Mesenchymal Lineage Stem Cells Have Pronounced Anti-Inflammatory Effects in the Twitcher Mouse Model of Krabbe's DiseaseStem Cells, 2010
- Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophyBrain Research, 2009
- Enzyme replacement therapy results in substantial improvements in early clinical phenotype in a mouse model of globoid cell leukodystrophyThe FASEB Journal, 2005
- AAV-Mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophyMolecular Therapy, 2005
- Neurological and neurobehavioral development of the mutant ‘twitcher’ mouseBehavioural Brain Research, 1987